ClariMedClariMed
Recherchen nahtlos fortsetzen
30 Sek mit Email - kein Passwort, kein Formular. Ihr Verlauf bleibt auf jedem Gerät.

Verlauf

Keine Anfragen

WHO2021EN

Lymphatic filariasis: managing morbidity and preventing disability: an aide-mémoire for national programme managers, 2nd ed.

Zusammenfassung

Lymphatic filariasis - managing morbidity and preventing disability: An aide-mémoire for national programme managers, Second edition Lymphatic filariasis - managing morbidity and preventing disability: an aide-mémoire for national programme managers, second edition ISBN 978-92-4-001706-1 (electronic version) ISBN 978-92-4-001707-8 (print version) © World Health Organization 2021 Some rights reserved.

Kerninformationen

r national programme managers, second edition. Geneva: World Health Organization; 2021. Licence: CC BY-NC- SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris. Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/boo...
or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use. iii Contents Contents iii Acknowledgements v New in this edition vi Glossary vii The Global Programme to Eliminate Ly...
ex 3. Management for seven stages of lymphoedema (or elephantiasis) 43 Annex 4. Algorithm for determining the management of acute attacks 44 Annex 5. Example of steps for home-based management of lymphoedema (or elephantiasis) 45 Annex 6: Community Morbidity Register 47 Annex 7: Examples of indi...
Originaldokument ansehen

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen

Verwandte Leitlinien